ClearPoint Neuro, Inc.
CLPTNASDAQHealthcareMedical Devices

About ClearPoint Neuro

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Company Information

CEOJoseph Burnett
Founded1998
Employees115
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone888 287 9109
Address
120 S. Sierra Avenue, Suite 100 Solana Beach, California 92075 United States

Corporate Identifiers

CIK0001285550
CUSIP18507C103
ISINUS18507C1036
EIN58-2394628
SIC3841

Leadership Team & Key Executives

Joseph Michael Burnett
President, Chief Executive Officer and Director
Danilo D'Alessandro
Chief Financial Officer
Jeremy L. Stigall
Chief Business Officer
Mazin Sabra
Chief Operating Officer
Ellisa Cholapranee J.D.
General Counsel and Secretary